• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GSS
Click for more information
0.74% 68.5¢

GENETIC SIGNATURES LIMITED - Charts / Financials

Market Cap $155.4M  ! watchlist Created with Sketch. Add to my watchlist

Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx)... Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx) company. The Company's principal activities include research and commercialization of identifying individual genetic signatures to identify diseases and the sale of associated products into the diagnostic and research marketplaces. The Company is focused on the development and commercialization of its platform technology, 3base. Its MDx 3base platform technology provides high-volume hospitals and pathology laboratories with the ability to screen for an array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment. It designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen brand. Its products include EasyScreen Pan-Enteric Detection Kit, EasyScreen STI Genital Pathogen Detection, EasyScreen Viral Meningitis Detection Kit, and others. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.37pm 28/11/2024 (20 minute delay) ?
Day
Open 68.5¢   Day High 68.5¢   Day Low 68.5¢
Daily Volume 11520
Bids   Sellers
Number Price Volume   Number Price Volume
1 68.5¢ 2851   1 69.0¢ 125000

Directors & Senior Management

Dr. Neil Gunn Non-Executive Director
Mr. Karl Pechmann Chief Financial Officer, Chief Operating Officer, Company Secretary
Mr. Michael Anton Aicher Executive Director - US Operations
Dr. Nickolaos Samaras Non-Executive Chairman of the Board
Mr. Stephane Chatonsky Non-Executive Director
Mrs. Caroline C. Waldron Non-Executive Chairman of the Board

Data source: Refinitiv

(20min delay)
Last
68.5¢ 		Change
0.005(0.74%) 		Mkt cap ! $155.4M
Open High Low Value Volume
68.5¢ 68.5¢ 68.5¢ $7.891K 11.52K

Buyers (Bids)

No. Vol. Price($)
1 2851 68.5¢
 

Sellers (Offers)

Price($) Vol. No.
69.0¢ 125000 1
View Market Depth
Last trade - 14.21pm 28/11/2024 (20 minute delay) ?
Last
68.8¢ 		  Change
0.005 ( 0.36 %)
Open High Low Volume
68.8¢ 68.8¢ 68.8¢ 4364
Last updated 15.37pm 28/11/2024 ?

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals Pro Medicus Ltd is set to roll out a suite of diagnostic imaging products across the health care system run by Trinity Health
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.